BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 1746574)

  • 1. Sterility testing of antimicrobial-containing injectable solutions prepared in the pharmacy.
    Akers MJ; Wright GE; Carlson KA
    Am J Hosp Pharm; 1991 Nov; 48(11):2414-8. PubMed ID: 1746574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals.
    Crawford SY; Narducci WA; Augustine SC
    Am J Hosp Pharm; 1991 Nov; 48(11):2398-413. PubMed ID: 1746573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of two sterility testing methods for intravenous admixtures.
    Condella F; Eichelberger K; Foote LC; Griffin RE
    Hosp Pharm; 1980 Jun; 15(6):305-10. PubMed ID: 10247270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a device for monitoring sterility of injectable fluids.
    Mayhall CG; Pierpaoli PG; Hall GO; Thomas RB
    Am J Hosp Pharm; 1981 Aug; 38(8):1148-50. PubMed ID: 6791498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Method for testing the sterility of total nutrient admixtures.
    Levchuk JW; Nolly RJ; Lander N
    Am J Hosp Pharm; 1988 Jun; 45(6):1311-21. PubMed ID: 3137813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of the aseptic processing environment.
    Frieben WR
    Am J Hosp Pharm; 1983 Nov; 40(11):1928-35. PubMed ID: 6650522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane filtration of pharmaceutical solutions.
    McKinnon BT; Avis KE
    Am J Hosp Pharm; 1993 Sep; 50(9):1921-36. PubMed ID: 8135243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incubation period in sterility testing.
    Bathgate H; Lazzari D; Cameron H; McKay D
    J Parenter Sci Technol; 1993; 47(5):254-7. PubMed ID: 8263662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of the first 6 months' experience in the monitoring of the sterility of injectable solutions].
    Pappalardo G
    Rev Med Suisse Romande; 1986 Feb; 106(2):163-71. PubMed ID: 3515496
    [No Abstract]   [Full Text] [Related]  

  • 10. Determining a time frame for sterility testing of intravenous admixtures.
    DeChant RL; Furtado D; Smith FM; Godwin HN; Domann DE
    Am J Hosp Pharm; 1982 Aug; 39(8):1305-8. PubMed ID: 6751079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products.
    Khuu HM; Stock F; McGann M; Carter CS; Atkins JW; Murray PR; Read EJ
    Cytotherapy; 2004; 6(3):183-95. PubMed ID: 15203975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adventitious contamination of intravenous admixtures during sterility testing.
    Bernick JJ; Brown DG; Bell JE
    Am J Hosp Pharm; 1979 Nov; 36(11):1493-6. PubMed ID: 517534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP; Hall KW
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiologic quality assurance for intravenous admixtures in a small hospital.
    Doss HL; James JD; Killough DM; Snodgrass GL
    Am J Hosp Pharm; 1982 May; 39(5):832-5. PubMed ID: 6805321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Microbiological control of drugs with antimicrobial properties with membrane filtration: problems, proposals, prospects].
    Negretti F
    Boll Chim Farm; 1997 Jan; 136(1):28-38. PubMed ID: 9131906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential elements of quality control.
    Boylan JC
    Am J Hosp Pharm; 1983 Nov; 40(11):1936-9. PubMed ID: 6650523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of three methods for detecting bacterial contamination in intravenous solutions.
    Hoffman KH; Smith FM; Godwin HN; Hogan LC; Furtado D
    Am J Hosp Pharm; 1982 Aug; 39(8):1299-302. PubMed ID: 6751078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of three methods for detecting low-level bacterial contamination in intravenous solutions.
    Miller CM; Furtado D; Smith FM; Godwin HN; Hogan LC; Letendre DE
    Am J Hosp Pharm; 1982 Aug; 39(8):1302-5. PubMed ID: 6812414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating aseptic technique of pharmacy personnel.
    Brier KL
    Am J Hosp Pharm; 1983 Mar; 40(3):400-3. PubMed ID: 6342376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The essentials of United States Pharmacopeia Chapter <51> antimicrobial effectiveness testing and its application in pharmaceutical compounding.
    Vu N; Nguyen K; Kupiec TC
    Int J Pharm Compd; 2014; 18(2):123-30. PubMed ID: 24881116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.